These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22174513)

  • 21. Imaging carotid body chemodectomas with ⁶⁸Ga-DOTA-NOC PET-CT.
    Naswa N; Kumar A; Sharma P; Bal C; Malhotra A; Kumar R
    Br J Radiol; 2012 Aug; 85(1016):1140-5. PubMed ID: 22096221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
    Khor LK; Loi HY; Sinha AK; Tong KT; Goh BC; Loh KS; Lu SJ
    Head Neck; 2016 Apr; 38(4):E76-80. PubMed ID: 26275126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of three cold kit reconstitution techniques for the reduction of hand radiation dose.
    Bogsrud TV; Herold TJ; Mahoney DW; Hung JC
    Nucl Med Commun; 1999 Aug; 20(8):761-7. PubMed ID: 10451885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individual dose monitoring of the nuclear medicine departments staff controlled by Central Laboratory for Radiological Protection.
    Szewczak K; Jednoróg S; Krajewski P
    Nucl Med Rev Cent East Eur; 2013; 16(2):62-5. PubMed ID: 24068634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gallium-68-DOTA-NOC PET/CT of patients with gastroenteropancreatic neuroendocrine tumors: a prospective single-center study.
    Naswa N; Sharma P; Kumar A; Nazar AH; Kumar R; Chumber S; Bal C
    AJR Am J Roentgenol; 2011 Nov; 197(5):1221-8. PubMed ID: 22021518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Personnel exposure in labelling and administration of (177)Lu-DOTA-D-Phe1-Tyr3-octreotide.
    Sghedoni R; Grassi E; Fioroni F; Asti M; Piccagli V; Versari A; Iori M
    Nucl Med Commun; 2011 Oct; 32(10):947-53. PubMed ID: 21876406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours.
    Ambrosini V; Tomassetti P; Castellucci P; Campana D; Montini G; Rubello D; Nanni C; Rizzello A; Franchi R; Fanti S
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1431-8. PubMed ID: 18418596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exposure of treating physician to radiation during prostate brachytherapy using iodine-125 seeds: dose measurements on both hands with thermoluminescence dosimeters.
    Schiefer H; von Toggenburg F; Seelentag W; Plasswilm L; Ries G; Lenggenhager C; Schmid HP; Leippold T; Prikler L; Krusche B; Roth J; Engeler D
    Strahlenther Onkol; 2009 Oct; 185(10):689-95. PubMed ID: 19806335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Finger doses for staff handling radiopharmaceuticals in nuclear medicine.
    Pant GS; Sharma SK; Rath GK
    J Nucl Med Technol; 2006 Sep; 34(3):169-73. PubMed ID: 16951286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET.
    Fanti S; Ambrosini V; Tomassetti P; Castellucci P; Montini G; Allegri V; Grassetto G; Rubello D; Nanni C; Franchi R
    Biomed Pharmacother; 2008 Dec; 62(10):667-71. PubMed ID: 18358680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine tumor imaging with 68Ga-DOTA-NOC: physiologic and benign variants.
    Kagna O; Pirmisashvili N; Tshori S; Freedman N; Israel O; Krausz Y
    AJR Am J Roentgenol; 2014 Dec; 203(6):1317-23. PubMed ID: 25415711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of
    Patil VA; Goroshi MR; Shah H; Malhotra G; Hira P; Sarathi V; Lele VR; Jadhav S; Lila A; Bandgar TR; Shah NS
    World J Nucl Med; 2020; 19(2):99-105. PubMed ID: 32939195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. External radiation exposure of personnel working with 99mTechnetium.
    Schürnbrand P; Schicha H; Thal H; Emrich D
    Eur J Nucl Med; 1982; 7(5):237-9. PubMed ID: 7094926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary safety evaluation of a cyclotron facility for positron emission tomography imaging.
    González L; Vañó E; Cordeiro CA; Carreras JL
    Eur J Nucl Med; 1999 Aug; 26(8):894-9. PubMed ID: 10436203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy.
    Gabriel M; Oberauer A; Dobrozemsky G; Decristoforo C; Putzer D; Kendler D; Uprimny C; Kovacs P; Bale R; Virgolini IJ
    J Nucl Med; 2009 Sep; 50(9):1427-34. PubMed ID: 19690033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT.
    Prasad V; Ambrosini V; Hommann M; Hoersch D; Fanti S; Baum RP
    Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):67-77. PubMed ID: 19618183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between Standardized Uptake Value of
    Kaewput C; Suppiah S; Vinjamuri S
    World J Nucl Med; 2018; 17(1):34-40. PubMed ID: 29398963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation exposure to nuclear medicine technologists performing a V/Q PET: Comparison with conventional V/Q scintigraphy, [
    Blanc-Béguin F; Damien P; Floch R; Kerleguer K; Hennebicq S; Robin P; Salaün PY; Le Roux PY
    Front Med (Lausanne); 2022; 9():1051249. PubMed ID: 36530884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of 68Ga-DOTA-NOC PET/CT in evaluating neuroendocrine tumors: real-world experience from two large neuroendocrine tumor centers.
    Haidar M; Shamseddine A; Panagiotidis E; Jreige M; Mukherji D; Assi R; Abousaid R; Ibrahim T; Haddad MM; Vinjamuri S
    Nucl Med Commun; 2017 Feb; 38(2):170-177. PubMed ID: 27922538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.
    Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF
    Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.